United States   Tech   Markets   Politics   Business   Science   Memes  









weight loss drug 




Sort By:                     

📉   Lilly's Weight-Loss Pill Data Achieves "Best-Case Scenario", Sending Rival Novo Shares Into Abyss

politics

Eli Lilly shares surged 16% in late afternoon trading—marking their largest intraday gain since August 2023—after the pharmaceutical giant announced earlier that its new weight-loss pill met efficacy goals in a late-stage trial, intensifying—if not turbocharging—its rivalry with Ozempic maker Novo Nordisk.

ZeroHedge Opinion     Apr 17, 2025